Posts Tagged ‘pertussis’

Maynard Group’s Preclinical Findings Bring Whooping Cough Treatment Closer to Human Trials

Posted on:
Maynard Group’s Preclinical Findings Bring Whooping Cough Treatment Closer to Human Trials

Texas ChE researchers recently published preclinical test results showing the use of antibodies in mice and baboons was successful in providing short-term immunity and an accelerated recovery from pertussis, also known as whooping cough. The findings, which were published in a paper on Dec. 2 in Science Translational Medicine, will help advance the treatment … Read the rest »

Jennifer Maynard Named Emerging Inventor of the Year

Posted on:

Undergraduate Alex Prybutok’s Whooping Cough Vaccine Poster Places Second At AIChE

Posted on:
Undergraduate Alex Prybutok’s Whooping Cough Vaccine Poster Places Second At AIChE

Undergraduate Alex Prybutok won second place in the Division of Food, Pharmaceuticals, and Biotechnology Poster Competition at the American Institute of Chemical Engineers Annual Meeting in Atlanta.

Alex’s winning poster featured research she is conducting in Dr. Jennifer Maynard’s labto improve therapeutics to fight pertussis, more commonly known as Whooping Cough. Each year … Read the rest »

Finding A Better Way To Fight Whooping Cough

Posted on:

Maynard Teams Up With Synthetic Biologics To Fight Whooping Cough

Posted on:
Maynard Teams Up With Synthetic Biologics To Fight Whooping Cough

Associate Professor Jennifer Maynard, the Laurence E. McMakin, Jr. Centennial Faculty Fellow, has teamed up with biotech company Synthetic Biologics, Inc. to develop a monoclonal antibody (mAb) therapy for the treatment of pertussis, commonly known as whooping cough.

Whooping cough causes an estimated 294,000 deaths annually worldwide, primarily among young, unvaccinated children.  Recent reports … Read the rest »